Literature DB >> 19171783

A phosphorylation-acetylation switch regulates STAT1 signaling.

Oliver H Krämer1, Shirley K Knauer, Georg Greiner, Enrico Jandt, Sigrid Reichardt, Karl-Heinz Gührs, Roland H Stauber, Frank D Böhmer, Thorsten Heinzel.   

Abstract

Cytokines such as interferons (IFNs) activate signal transducers and activators of transcription (STATs) via phosphorylation. Histone deacetylases (HDACs) and the histone acetyltransferase (HAT) CBP dynamically regulate STAT1 acetylation. Here we show that acetylation of STAT1 counteracts IFN-induced STAT1 phosphorylation, nuclear translocation, DNA binding, and target gene expression. Biochemical and genetic experiments altering the HAT/HDAC activity ratio and STAT1 mutants reveal that a phospho-acetyl switch regulates STAT1 signaling via CBP, HDAC3, and the T-cell protein tyrosine phosphatase (TCP45). Strikingly, inhibition of STAT1 signaling via CBP-mediated acetylation is distinct from the functions of this HAT in transcriptional activation. STAT1 acetylation induces binding of TCP45, which catalyzes dephosphorylation and latency of STAT1. Our results provide a deeper understanding of the modulation of STAT1 activity. These findings reveal a new layer of physiologically relevant STAT1 regulation and suggest that a previously unidentified balance between phosphorylation and acetylation affects cytokine signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171783      PMCID: PMC2648535          DOI: 10.1101/gad.479209

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  52 in total

1.  Antiviral activity of oligomerization-deficient Stat1.

Authors:  Uwe Vinkemeier; Thomas Meyer
Journal:  Genome Inform       Date:  2005

2.  Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain.

Authors:  Claudia Mertens; Minghao Zhong; Ravi Krishnaraj; Wenxin Zou; Xiaomin Chen; James E Darnell
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

Review 3.  Structure, function, and regulation of STAT proteins.

Authors:  Cheh Peng Lim; Xinmin Cao
Journal:  Mol Biosyst       Date:  2006-09-26

Review 4.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

5.  Acetylation of Stat1 modulates NF-kappaB activity.

Authors:  Oliver H Krämer; Daniela Baus; Shirley K Knauer; Stefan Stein; Elke Jäger; Roland H Stauber; Manuel Grez; Edith Pfitzner; Thorsten Heinzel
Journal:  Genes Dev       Date:  2006-02-15       Impact factor: 11.361

6.  Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein.

Authors:  Jana Vlasáková; Zora Nováková; Lenka Rossmeislová; Michal Kahle; Pavel Hozák; Zdenek Hodny
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

Review 7.  STAT1 as a key modulator of cell death.

Authors:  Hun Sik Kim; Myung-Shik Lee
Journal:  Cell Signal       Date:  2006-09-30       Impact factor: 4.315

8.  IFN-gamma protects cerulein-induced acute pancreatitis by repressing NF-kappa B activation.

Authors:  Takahito Hayashi; Yuko Ishida; Akihiko Kimura; Yoichiro Iwakura; Naofumi Mukaida; Toshikazu Kondo
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 9.  How cells respond to interferons revisited: from early history to current complexity.

Authors:  George R Stark
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-01       Impact factor: 7.638

10.  Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene.

Authors:  Katrin Ramsauer; Matthias Farlik; Gordin Zupkovitz; Christian Seiser; Andrea Kröger; Hansjörg Hauser; Thomas Decker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

View more
  113 in total

1.  Smurf1 protein negatively regulates interferon-γ signaling through promoting STAT1 protein ubiquitination and degradation.

Authors:  Chao Yuan; Jianni Qi; Xueying Zhao; Chengjiang Gao
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

4.  SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.

Authors:  Thang Van Nguyen; Pornpimon Angkasekwinai; Hong Dou; Feng-Ming Lin; Long-Sheng Lu; Jinke Cheng; Y Eugene Chin; Chen Dong; Edward T H Yeh
Journal:  Mol Cell       Date:  2012-01-27       Impact factor: 17.970

5.  Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Authors:  Olivia Perwitasari; Hyelim Cho; Michael S Diamond; Michael Gale
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

6.  Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis.

Authors:  Jinah Park; Junil Kim; Bora Park; Kyung-Min Yang; Eun Jin Sun; Cristina E Tognon; Poul H Sorensen; Seong-Jin Kim
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

7.  Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.

Authors:  Ewa M Kosciuczuk; Swarna Mehrotra; Diana Saleiro; Barbara Kroczynska; Beata Majchrzak-Kita; Pawel Lisowski; Caroline Driehaus; Anna Rogalska; Acara Turner; Thomas Lienhoop; David Gius; Eleanor N Fish; Athanassios Vassilopoulos; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

8.  HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models.

Authors:  Eva Benito; Hendrik Urbanke; Binu Ramachandran; Jonas Barth; Rashi Halder; Ankit Awasthi; Gaurav Jain; Vincenzo Capece; Susanne Burkhardt; Magdalena Navarro-Sala; Sankari Nagarajan; Anna-Lena Schütz; Steven A Johnsen; Stefan Bonn; Reinhardt Lührmann; Camin Dean; André Fischer
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

Review 9.  Metabolic reprogramming by class I and II histone deacetylases.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Trends Endocrinol Metab       Date:  2012-10-09       Impact factor: 12.015

Review 10.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.